日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma

伊比度胺可增加复发/难治性多发性骨髓瘤患者骨髓中的先天性和适应性免疫细胞亚群。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2024.101584
Van Oekelen, Oliver; Amatangelo, Michael; Guo, Manman; Upadhyaya, Bhaskar; Cribbs, Adam P; Kelly, Geoffrey; Patel, Manishkumar; Kim-Schulze, Seunghee; Flynt, Erin; Lagana, Alessandro; Gooding, Sarah; Merad, Miriam; Jagganath, Sundar; Pierceall, William E; Oppermann, Udo; Thakurta, Anjan; Parekh, Samir
多发性骨髓瘤
细胞生物学
免疫/内分泌
骨髓瘤
发表日期：2024
文献求助 收藏

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

在接受泊马度胺联合硼替佐米和地塞米松治疗的复发/难治性多发性骨髓瘤患者中，NK、NKT 和 B/T 细胞亚型的免疫调节及其与无进展生存期改善的相关性

期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2023.1271807
Rao Prabhala # ，William E Pierceall # ，Mehmet Samur # ，Lakshmi B Potluri # ，Kevin Hong ，Teresa Peluso ，Srikanth Talluri ，Angela Wang ，Aishwarya Katiki ，Sahan D Vangala ，Michael Buonopane ，Vaishnavi Bade ，Hannah Seah ，Arthur Krogman ，Sanika Derebail ，Mariateresa Fulciniti ，Suzan B Lazo ，Paul Richardson ，Kenneth Anderson ，Jill Corre ，Herve Avet-Loiseau ，Anjan Thakurta ，Nikhil Munshi
免疫/内分泌
T细胞
多发性骨髓瘤
骨髓瘤
细胞生物学
发表日期：2023
文献求助 收藏

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma

2q37位点COP9信号体基因的缺失与多发性骨髓瘤的IMiD耐药性相关

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022015909
Gooding, Sarah; Ansari-Pour, Naser; Kazeroun, Mohammad; Karagoz, Kubra; Polonskaia, Ann; Salazar, Mirian; Fitzsimons, Evie; Sirinukunwattana, Korsuk; Chavda, Selina; Ortiz Estevez, Maria; Towfic, Fadi; Flynt, Erin; Pierceall, William; Royston, Daniel; Yong, Kwee; Ramasamy, Karthik; Vyas, Paresh; Thakurta, Anjan
信号转导
骨髓瘤
多发性骨髓瘤
发表日期：2022
文献求助 收藏

Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma

骨髓瘤基因组计划小组是一个全面的靶向基因组学小组，用于对多发性骨髓瘤患者进行分子分析

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-21-3695
Parvathi Sudha #, Aarif Ahsan #, Cody Ashby, Tasneem Kausar, Akhil Khera, Mohammad H Kazeroun, Chih-Chao Hsu, Lin Wang, Evelyn Fitzsimons, Outi Salminen, Patrick Blaney, Magdalena Czader, Jonathan Williams, Mohammad I Abu Zaid, Naser Ansari-Pour, Kwee L Yong, Frits van Rhee, William E Pierceall, Gar
肿瘤
骨髓瘤
发表日期：2022
文献求助 收藏

Multiple Myeloma Patient Tumors With High Levels of Cereblon Exon-10 Deletion Splice Variant Upregulate Clinically Targetable Pro-Inflammatory Cytokine Pathways

多发性骨髓瘤患者肿瘤中高水平的Cereblon外显子10缺失剪接变体上调临床可靶向的促炎细胞因子通路

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.831779
Karagoz, Kubra; Stokes, Matthew; Ortiz-Estévez, María; Towfic, Fadi; Flynt, Erin; Gooding, Sarah; Pierceall, William; Thakurta, Anjan
信号转导
多发性骨髓瘤
骨髓瘤
免疫/内分泌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2022
文献求助 收藏

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma

一项针对NUT癌、其他实体瘤或弥漫性大B细胞淋巴瘤患者的RO6870810（一种新型溴结构域和末端外蛋白抑制剂）的I期研究

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-020-01180-1
Shapiro, Geoffrey I; LoRusso, Patricia; Dowlati, Afshin; T Do, Khanh; Jacobson, Caron A; Vaishampayan, Ulka; Weise, Amy; Caimi, Paolo F; Eder, Joseph Paul; French, Christopher A; Labriola-Tompkins, Emily; Boisserie, Frédéric; Pierceall, William E; Zhi, Jianguo; Passe, Sharon; DeMario, Mark; Kornacker, Martin; Armand, Philippe
B细胞
肿瘤
肿瘤免疫
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma

开发下一代免疫调节药物及其联合疗法治疗多发性骨髓瘤

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.27973
Thakurta, Anjan; Pierceall, William E; Amatangelo, Michael D; Flynt, Erin; Agarwal, Amit
多发性骨髓瘤
免疫/内分泌
骨髓瘤
发表日期：2021
文献求助 收藏

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN

伊比度胺 (CC-220) 是一种强效的 cereblon E3 连接酶调节剂，对 CRBN 失调的来那度胺和泊马度胺耐药的多发性骨髓瘤细胞具有抗肿瘤和免疫刺激活性。

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-019-0620-8
Bjorklund, Chad C; Kang, Jian; Amatangelo, Michael; Polonskaia, Ann; Katz, Mark; Chiu, Hsiling; Couto, Suzana; Wang, Maria; Ren, Yan; Ortiz, Maria; Towfic, Fadi; Flynt, J Erin; Pierceall, William; Thakurta, Anjan
多发性骨髓瘤
CRBN
骨髓瘤
免疫/内分泌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2020
文献求助 收藏

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

泊马度胺、地塞米松和达雷妥尤单抗用于来那度胺治疗后复发难治性多发性骨髓瘤

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-020-0813-1
Siegel, David S; Schiller, Gary J; Samaras, Christy; Sebag, Michael; Berdeja, Jesus; Ganguly, Siddhartha; Matous, Jeffrey; Song, Kevin; Seet, Christopher S; Talamo, Giampaolo; Acosta-Rivera, Mirelis; Bar, Michael; Quick, Donald; Anz, Bertrand; Fonseca, Gustavo; Reece, Donna; Pierceall, William E; Chung, Weiyuan; Zafar, Faiza; Agarwal, Amit; Bahlis, Nizar J
骨髓瘤
多发性骨髓瘤
发表日期：2020
文献求助 收藏

Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure

泊马度胺联合低剂量地塞米松治疗来那度胺治疗失败后的复发难治性多发性骨髓瘤

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.16213
Siegel, David S; Schiller, Gary J; Song, Kevin W; Agajanian, Richy; Stockerl-Goldstein, Keith; Kaya, Hakan; Sebag, Michael; Samaras, Christy; Malek, Ehsan; Talamo, Giampaolo; Seet, Christopher S; Mouro, Jorge; Pierceall, William E; Zafar, Faiza; Chung, Weiyuan; Srinivasan, Shankar; Agarwal, Amit; Bahlis, Nizar J
多发性骨髓瘤
骨髓瘤
发表日期：2020
文献求助 收藏